- Home
- PAMT vs GHRS Comparison
PAMT vs GHRS Comparison
Compare PAMT & GHRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PAMT
- GHRS
- Stock Information
- Founded
- PAMT 1980
- GHRS 2018
- Country
- PAMT United States
- GHRS Ireland
- Employees
- PAMT N/A
- GHRS N/A
- Industry
- PAMT Trucking Freight/Courier Services
- GHRS Biotechnology: Pharmaceutical Preparations
- Sector
- PAMT Industrials
- GHRS Health Care
- Exchange
- PAMT Nasdaq
- GHRS Nasdaq
- Market Cap
- PAMT 356.4M
- GHRS 356.4M
- IPO Year
- PAMT 1985
- GHRS 2021
- Fundamental
- Price
- PAMT $16.64
- GHRS $8.88
- Analyst Decision
- PAMT
- GHRS Strong Buy
- Analyst Count
- PAMT 0
- GHRS 3
- Target Price
- PAMT N/A
- GHRS $35.67
- AVG Volume (30 Days)
- PAMT 42.0K
- GHRS 91.4K
- Earning Date
- PAMT 01-30-2025
- GHRS 02-27-2025
- Dividend Yield
- PAMT N/A
- GHRS N/A
- EPS Growth
- PAMT N/A
- GHRS N/A
- EPS
- PAMT N/A
- GHRS N/A
- Revenue
- PAMT $728,284,000.00
- GHRS N/A
- Revenue This Year
- PAMT N/A
- GHRS N/A
- Revenue Next Year
- PAMT $4.86
- GHRS N/A
- P/E Ratio
- PAMT N/A
- GHRS N/A
- Revenue Growth
- PAMT N/A
- GHRS N/A
- 52 Week Low
- PAMT $13.51
- GHRS $5.50
- 52 Week High
- PAMT $23.70
- GHRS $14.99
- Technical
- Relative Strength Index (RSI)
- PAMT N/A
- GHRS 57.07
- Support Level
- PAMT N/A
- GHRS $8.02
- Resistance Level
- PAMT N/A
- GHRS $10.23
- Average True Range (ATR)
- PAMT 0.00
- GHRS 0.88
- MACD
- PAMT 0.00
- GHRS 0.10
- Stochastic Oscillator
- PAMT 0.00
- GHRS 60.06
About PAMT PAMT CORP Common Stock
PAMT Corp is a holding company that is engaged in providing truckload dry van carriers transporting general commodities throughout the continental United States, as well as the Canadian provinces of Ontario and Quebec.
About GHRS GH Research PLC
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders. The company is focused on developing novel and proprietary Mebufotenin 5-Methoxy-N, N-Dimethyltryptamine, or 5-MeO-DMT, therapies for the treatment of patients with Treatment-Resistant Depression, or TRD.